Rheumatology

2025

1. Aortic, musculoskeletal and organ characteristics on computed tomography in knee osteoarthritis - an explorative study in the IMI-APPROACH cohort

   Rheumatology international, Vol. 45, Núm. 3, pp. 62

2. Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review

   Rheumatology international, Vol. 45, Núm. 4, pp. 91

3. Associations Between Soluble Cell Adhesion Molecules and Cardiovascular Comorbidities in Systemic Sclerosis: Implications for Insulin Resistance

   Journal of Clinical Medicine, Vol. 14, Núm. 5

4. Belimumab patient profile in Spain: evolution during the last decade and future directions

   Expert Opinion on Biological Therapy, Vol. 25, Núm. 4, pp. 425-435

5. Bisphosphonate drug holidays in osteoporosis according to fracture risk profile

   Osteoporosis International, Vol. 36, Núm. 2, pp. 245-254

6. Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact

   Seminars in Arthritis and Rheumatism, Vol. 73

7. Cartilage thickness distribution and its dependence on demographic, radiographic, and MRI structural pathology in knee osteoarthritis—data from the IMI-APPROACH cohort

   Skeletal Radiology

8. Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

   Rheumatology, Vol. 64, Núm. 6, pp. 3733-3738

9. Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project

   Arthritis and Rheumatology, Vol. 77, Núm. 4, pp. 477-489

10. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus

11. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus, Vol. 34, Núm. 6, pp. 571-578

12. DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

    Scientific Reports, Vol. 15, Núm. 1

13. Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

    Arthritis research & therapy, Vol. 27, Núm. 1, pp. 5

14. Disease-Associated Signatures Persist in Extracellular Vesicles from Reprogrammed Cells of Osteoarthritis Patients

    International Journal of Molecular Sciences, Vol. 26, Núm. 3

15. E74-like ETS transcription factor 3 expression and regulation in human intervertebral disc

    JOR Spine, Vol. 8, Núm. 1

16. ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

    The Lancet Rheumatology, Vol. 7, Núm. 7, pp. e505-e518

17. EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update

    Annals of the Rheumatic Diseases, Vol. 84, Núm. 6, pp. 899-909

18. Economic Impact of Allergic Diseases and Asthma—The HEAD Pan-European Registry

    Allergy: European Journal of Allergy and Clinical Immunology

19. EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis

    RMD Open, Vol. 11, Núm. 1

20. Effectiveness of a co-management program with internal medicine on hip fracture patients at a regional hospital in northwest Spain. Co-inter-Monf study

    European journal of trauma and emergency surgery : official publication of the European Trauma Society, Vol. 51, Núm. 1, pp. 23